CDXS
Codexis Inc (CDXS)
Healthcare • NASDAQ • $2.85+10.47%
- Symbol
- CDXS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $2.85
- Daily Change
- +10.47%
- Market Cap
- $259.06M
- Trailing P/E
- N/A
- Forward P/E
- -7.70
- 52W High
- $3.87
- 52W Low
- $0.96
- Analyst Target
- $6.10
- Dividend Yield
- N/A
- Beta
- N/A
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Company websiteResearch CDXS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.